Table 3

HR for stroke according to non-HDLC levels

Non-HDLC levelsP for trendPer 1 SD increase
<3.4 mmol/L3.4–4.2 mmol/L≥4.2 mmol/L
Total stroke
Events, n (%)10 (2.8)6 (3.4)3 (2.3)
 Model 1Ref.1.06 (0.38, 2.94)0.71 (0.19, 2.61)0.88 (0.49, 1.59)0.96 (0.67, 1.39)
 Model 2Ref.1.44 (0.50, 4.22)0.83 (0.21, 3.25)0.98 (0.54, 1.80)1.00 (0.74, 1.35)
Ischaemic stroke
Events, n (%)6 (1.7)2 (1.1)2 (1.5)
 Model 1Ref.0.56 (0.11, 2.79)0.75 (0.15, 3.79)0.81 (0.35, 1.86)0.94 (0.61, 1.47)
 Model 2Ref.0.73 (0.14, 3.89)0.65 (0.12, 3.67)0.80 (0.34, 1.86)0.99 (0.75, 1.32)
Intracerebral haemorrhage
Events, n (%)4 (1.1)4 (2.3)2 (1.5)
 Model 1Ref.1.86 (0.46, 7.52)1.24 (0.22, 6.89)1.18 (0.55, 2.54)1.01 (0.53, 1.94)
 Model 2Ref.2.84 (0.61, 13.14)1.80 (0.28, 11.53)1.41 (0.63, 3.19)1.07 (0.52, 2.21)
  • Data are HR (95% CI) unless otherwise stated.

  • Model 1 adjusted for age and sex.

  • Model 2 adjusted for variates in model 1 plus prior mRS scale (<3 or ≥3) history of ICH, glucose on admission, WCC on admission, baseline haematoma volume, haematoma location, time from onset to initial non-contrast CT, GCS score at admission, systolic blood pressure.

  • GCS, Glasgow Coma Scale; ICH, intracerebral haemorrhage; mRS, modified Ranking Scale; Non-HDLC, non-high-density lipoprotein cholesterol; WCC, white cell count.